• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Arch Microbiol . . Preparation and characterization of a Llama VHH-hFc chimeric antibody recognizing conserved neutralization epitope of H5N1 hemagg

tetano

Editor, Senior Moderator
Arch Microbiol


. 2025 Sep 8;207(10):252.
doi: 10.1007/s00203-025-04460-7. Preparation and characterization of a Llama VHH-hFc chimeric antibody recognizing conserved neutralization epitope of H5N1 hemagglutinin with high affinity

Lingyan Liu[SUP] 1 [/SUP], Liliang Xia[SUP] 2 [/SUP], Biao Wu[SUP] 2 [/SUP], Ying Wang[SUP] 2 3 [/SUP], Jie Xu[SUP] 4 5 [/SUP]



Affiliations
Abstract

Highly pathogenic avian influenza (HPAI) H5N1 virus poses a continuing global public health threat due to its outbreaks in poultry farms and zoonotic transmission from birds to humans. In the quest of effective therapeutics against H5N1 infection, antibodies with broad neutralizing activity have attracted significant attention. In this study, we employed a phage display technique to select and identify VHH antibodies with specific neutralizing activity against H5N1 hemagglutinin (HA) from an immune llama-derived antibody library. Subsequently, we prepared fusions of VHH10 antibody with human Fc fragment. The chimeric antibody VHH10-hFc was characterized and evaluated for its specificity, binding affinity, serum persistence and antigen recognition epitope. Following purification from 293 F cell cultures, VHH10-hFc chimeric antibody retained its specificity to H5N1 HA. Its antigen-binding affinity was enhanced by up to 130-fold, and its serum persistence was extended by up to 170-fold compared to VHH10. The VHH10-hFc chimeric antibody demonstrated high affinity, excellent thermal stability, and broad reactivity against H5N1 HA in clades 0, 1, 2, and 4. Through epitope mapping, we identified a conformational epitope consisting amino acid residues at positions Q187, K189, L190, Y191, N193, T215, S217 and N220 located on the top region of HA, which was specific and conserved epitopes among H5N1 strains. Consequently, VHH10-hFc, with great specificity, high affinity, prolonged serum persistence and good thermal stability, recognizes a conserved neutralization epitope on the globular head of H5N1 HA, indicating great potential in therapeutic strategies against H5N1 infection.

Keywords: Chimeric antibody; Conserved neutralization epitope; H5N1 hemagglutinin; VHH antibody.

 
Back
Top Bottom